Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-28

Clinical Trial Update: Pharmacokinetics of Two Formulation of Pregabalin [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study comparing two formulations of pregabalin has been completed, evaluating effects in diabetic peripheral neuropathy, fibromyalgia, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Diabetic Peripheral Neuropathy, Fibromyalgia | Phase 4 | Status: COMPLETED